SEC Comment Letter 0000000000-23-009068 to MAIA Biotechnology, Inc. (MAIA) (CIK 0001878313) (MAIA)
MAIA Biotechnology, Inc. (MAIA) (CIK 0001878313)
Date: Aug. 18, 2023 · CIK: 0001878313 · Accession: 0000000000-23-009068
AI Filing Summary & Sentiment
File numbers found in text: 333-273984
Letter
United States securities and exchange commission logo August 18, 2023 Vlad Vitoc Chief Executive Officer MAIA Biotechnology, Inc. 444 West Lake Street, Suite 1700 Chicago, IL 60606 Re:MAIA Biotechnology, Inc. Registration Statement on Form S-3 Filed August 15, 2023 File No. 333-273984 Dear Vlad Vitoc: This is to advise you that we have not reviewed and will not review your registration statement. Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you that the company and its management are responsible for the accuracy and adequacy of their disclosures, notwithstanding any review, comments, action or absence of action by the staff. Please contact Alan Campbell at 202-551-4224 with any questions. Sincerely, Division of Corporation Finance Office of Life Sciences cc: Blake J. Baron, Esq.
Show Raw Text
United States securities and exchange commission logo
August 18, 2023
Vlad Vitoc
Chief Executive Officer
MAIA Biotechnology, Inc.
444 West Lake Street, Suite 1700
Chicago, IL 60606
Re:MAIA Biotechnology, Inc.
Registration Statement on Form S-3
Filed August 15, 2023
File No. 333-273984
Dear Vlad Vitoc:
This is to advise you that we have not reviewed and will not review your registration
statement.
Please refer to Rules 460 and 461 regarding requests for acceleration. We remind you
that the company and its management are responsible for the accuracy and adequacy of their
disclosures, notwithstanding any review, comments, action or absence of action by the staff.
Please contact Alan Campbell at 202-551-4224 with any questions.
Sincerely,
Division of Corporation Finance
Office of Life Sciences
cc: Blake J. Baron, Esq.